148 related articles for article (PubMed ID: 23250696)
21. Serum proteome profiling of primary breast cancer indicates a specific biomarker profile.
Böhm D; Keller K; Wehrwein N; Lebrecht A; Schmidt M; Kölbl H; Grus FH
Oncol Rep; 2011 Nov; 26(5):1051-6. PubMed ID: 21837365
[TBL] [Abstract][Full Text] [Related]
22. Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).
Roobol MJ; Bangma CH; el Bouazzaoui S; Franken-Raab CG; Zwarthoff EC
Urol Oncol; 2010; 28(6):686-90. PubMed ID: 21062653
[TBL] [Abstract][Full Text] [Related]
23. Assessment of novel combinations of biomarkers for the detection of colorectal cancer.
Shimwell NJ; Wei W; Wilson S; Wakelam MJ; Ismail T; Iqbal T; Johnson PJ; Martin A; Ward DG
Cancer Biomark; 2010; 7(3):123-32. PubMed ID: 21263188
[TBL] [Abstract][Full Text] [Related]
24. Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.
Ambeba E; Linkov F
Future Oncol; 2011 Dec; 7(12):1399-414. PubMed ID: 22112316
[TBL] [Abstract][Full Text] [Related]
25. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
26. Cell-free DNA concentration and integrity as a screening tool for cancer.
Zaher ER; Anwar MM; Kohail HM; El-Zoghby SM; Abo-El-Eneen MS
Indian J Cancer; 2013; 50(3):175-83. PubMed ID: 24061455
[TBL] [Abstract][Full Text] [Related]
27. The cautionary tale of PSA testing.
Hoffman RM; Zeliadt SB
Arch Intern Med; 2010 Jul; 170(14):1262-3. PubMed ID: 20660847
[No Abstract] [Full Text] [Related]
28. Risks of online direct-to-consumer tumor markers for cancer screening.
Lovett KM; Liang BA; Mackey TK
J Clin Oncol; 2012 May; 30(13):1411-4. PubMed ID: 22355060
[No Abstract] [Full Text] [Related]
29. Pooling of case specimens to create standard serum sets for screening cancer biomarkers.
Skates SJ; Horick NK; Moy JM; Minihan AM; Seiden MV; Marks JR; Sluss P; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):334-41. PubMed ID: 17301268
[TBL] [Abstract][Full Text] [Related]
30. Personalizing ovarian cancer screening.
Goozner M
J Natl Cancer Inst; 2010 Aug; 102(15):1112-3. PubMed ID: 20668268
[No Abstract] [Full Text] [Related]
31. [Establishment and application of standard serum proteomic pattern for diagnosis of early liver cancer].
Chen R; Chen XP; Lin QQ; Lin BL; Cao HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):341-3. PubMed ID: 21354926
[TBL] [Abstract][Full Text] [Related]
32. [Mass screening and early diagnosis of cancers. Which methods are efficient?].
Chauvin F
Rev Prat; 2010 Feb; 60(2):175-7. PubMed ID: 20225550
[No Abstract] [Full Text] [Related]
33. Landmarks in prostate cancer diagnosis: the biomarkers.
Artibani W
BJU Int; 2012 Oct; 110 Suppl 1():8-13. PubMed ID: 23046035
[TBL] [Abstract][Full Text] [Related]
34. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
Chang IH; Ahn SH; Han JH; Kim TH; Kim YS; Myung SC
J Urol; 2009 Feb; 181(2):567-72; discussion 572-3. PubMed ID: 19084848
[TBL] [Abstract][Full Text] [Related]
35. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
[TBL] [Abstract][Full Text] [Related]
36. Early detection of lung cancers - Comparison of computed tomography, cytology and fuzzy-based tumor markers panels.
Schneider J
Cancer Biomark; 2010; 6(3-4):149-62. PubMed ID: 20660961
[TBL] [Abstract][Full Text] [Related]
37. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
38. Oral mucosal color changes as a clinical biomarker for cancer detection.
Latini G; De Felice C; Barducci A; Chitano G; Pignatelli A; Grimaldi L; Tramacere F; Laurini R; Andreassi MG; Portaluri M
Eur J Cancer Prev; 2012 Jul; 21(4):360-6. PubMed ID: 22634938
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers for the early detection of cancer: an inflammatory concept.
Roy HK; Khandekar JD
Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
[No Abstract] [Full Text] [Related]
40. Discovery and application of protein biomarkers for ovarian cancer.
Gagnon A; Ye B
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
